Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Relapsed/Refractory Follicular Lymphoma With EZH2
View Full LandscapeTarget Indication
Relapsed/Refractory Follicular Lymphoma With EZH2
Clinical Trial
NCT05467943Last updated: 12/13/2025
No patent data available. Pre-approval drugs may not have Orange Book listings.
Advanced Renal Cell Carcinoma
Acute Myeloid Leukemia
Advanced Intrahepatic Cholangiocarcinoma
Metastatic Pancreatic Cancer
Advanced Endometrial Cancer